A dose-escalating toxicology study of the candidate biologic ELP-VEGF
Abstract Vascular Endothelial Growth Factor (VEGF), a key mediator of angiogenesis and vascular repair, is reduced in chronic ischemic renal diseases, leading to microvascular rarefaction and deterioration of renal function. We developed a chimeric fusion of human VEGF-A121 with the carrier protein...
Guardado en:
Autores principales: | Jamarius P. Waller, Stephen P. Burke, Jason Engel, Alejandro R. Chade, Gene L. Bidwell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a90e0ab576444fa94b0057516ab228f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide
por: Marija Kuna, et al.
Publicado: (2018) -
Nonlinearity in biology, toxicology, medicine
Publicado: (2003) -
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
por: Hui-Jen Tsai, et al.
Publicado: (2021) -
How does hormesis impact biology, toxicology, and medicine?
por: Edward J. Calabrese, et al.
Publicado: (2017) -
Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs
por: Axiak SM, et al.
Publicado: (2011)